Does adenocarcinoma of uterine cervix have a worse prognosis than squamous carcinoma?;Les adénocarcinomes du col utérin ont-ils un plus mauvais pronostic que les carcinomes épidermoïdes?

Gynecologie Obstetrique et Fertilite

Volumn 32, Issue 2, 2004, Pages 116-121

  Recoules Arche, A ^a   Rouzier, R ^a   Rey, A ^a   Villefranque, V ^a   Haie Meder, C ^a   Pautier, P ^a   Pomel, C ^a   Lhomme C ^a   Duvillard, P ^a   Castaigne, D ^a   Morice, P ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Adenocarcinoma; Ad nocarcinome; Cancer du col ut rin; Carcinome pidermo de; Cervical cancer; Facteurs pronostiques; Prognosis factors; Squamous cell carcinoma

Indexed keywords

CISPLATIN;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DATA BASE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYSTERECTOMY; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; PROGNOSIS; RADIOSENSITIVITY; SQUAMOUS CELL CARCINOMA; TISSUE SLICE; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA;

EID: 10744228661     PISSN: 12979589     EISSN: 17696682     Source Type: Journal    
DOI: 10.1016/j.gyobfe.2003.10.028     Document Type: Article

References (22)

1. Zheng T., Holford T.R., Ma Z., Chen Y., Liu W., Ward B.A., et al. The continuing increase in adenocarcinoma of the uterine cervix: a birth cohort phenomenon. Int J Epidemiol. 25:1996;252-258.
2. Eifel P.J., Burke T.W., Morris M., Smith T.L. Adenocarcinoma as an independent risk factor for disease recurrence in patients with stage IB cervical carcinoma. Gynecol Oncol. 59:1995;38-44.
3. Chen R.J., Lin Y.H., Chen C.A., Huang S.C., Chow S.N., Hsieh C.Y. Influence of histologic type and age on survival rates for invasive cervical carcinoma in Taiwan. Gynecol Oncol. 73:1999;184-190.
4. Martel P., Connan L., Bonnet F., Delannes M., Farnarier J., Mihura J., et al. Aspects diagnostiques, pronostiques et thérapeutiques des adénocarcinomes du col utérin: à propos d'une série de 49 cas. J Gynecol Obstet Biol Reprod (Paris). 29:2000;48-54.
5. Grigsby P.W., Perez C.A., Kuske R.R., Camel H.M., Kao M.S., Galakatos A.E., et al. Adenocarcinoma of the uterine cervix: lack of evidence for a poor prognosis. Radiother Oncol. 12:1988;289-296.
6. Grisaru D., Covens A., Chapman B., Shaw P., Colgan T., Murphy J., et al. Does histology influence prognosis in patients with early-stage cervical carcinoma? Cancer. 92:2001;2999-3004.
7. Look K.Y., Brunetto V.L., Clarke-Pearson D.L., Averette H.E., Major F.J., Alvarez R.D., et al. An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol. 63:1996;304-311.
8. Nakanishi T., Ishikawa H., Suzuki Y., Inoue T., Nakamura S., Kuzuya K. A comparison of prognoses of pathologic stage Ib adenocarcinoma and squamous cell carcinoma of the uterine cervix. Gynecol Oncol. 79:2000;289-293.
9. Shingleton H.M., Bell M.C., Fremgen A., Chmiel J.S., Russell A.H., Jones W.B., et al. Is there really a difference in survival of women with squamous cell carcinoma, adenocarcinoma, and adenosquamous cell carcinoma of the cervix? Cancer. 76:1995;1948-1955.
10. Schorge J.O., Hossein Saboorian M., Hynan L., Ashfaq R. ThinPrep detection of cervical and endometrial adenocarcinoma: a retrospective cohort study. Cancer. 96:2002;338-343.
11. Hopkins M.P., Peters W.A. 3rd, Andersen W., Morley G.W. Invasive cervical cancer treated initially by standard hysterectomy. Gynecol Oncol. 36:1990;7-12.
12. Anton-Culver H., Bloss J.D., Bringman D., Lee-Feldstein A., DiSaia P., Manetta A. Comparison of adenocarcinoma and squamous cell carcinoma of the uterine cervix: a population-based epidemiologic study. Am J Obstet Gynecol. 166:1992;1507-1514.
13. Harrison T.A., Sevin B.U., Koechli O., Nguyen H.N., Averette H.E., Penalver M., et al. Adenosquamous carcinoma of the cervix: prognosis in early stage disease treated by radical hysterectomy. Gynecol Oncol. 50:1993;310-315.
14. Resbeut M., Fondrinier E., Fervers B., Haie-Meder C., Bataillard A., Lhomme C., et al. Standards, options et recommandations pour la prise en charge de patientes atteintes de cancer invasif du col utérin (stades non métastatiques), version abrégée. Gynecol Obstet Fertil. 30:2002;631-648.
15. Kilgore L.C., Soong S.J., Gore H., Shingleton H.M., Hatch K.D., Partridge E.E. Analysis of prognostic features in adenocarcinoma of the cervix. Gynecol Oncol. 31:1988;137-153.
16. Berek J.S., Hacker N.F., Fu Y.S., Sokale J.R., Leuchter R.C., Lagasse L.D. Adenocarcinoma of the uterine cervix: histologic variables associated with lymph node metastasis and survival. Obstet Gynecol. 65:1985;46-52.
17. Morice P., Castaigne D., Pautier P., Rey A., Haie-Meder C., Leblanc M., et al. Interest of pelvic and paraaortic lymphadenectomy in patients with stage IB and II cervical carcinoma. Gynecol Oncol. 73:1999;106-110.
18. Fyles A.W., Pintilie M., Kirkbride P., Levin W., Manchul L.A., Rawlings G.A. Prognostic factors in patients with cervix cancer treated by radiation therapy: results of a multiple regression analysis. Radiother Oncol. 35:1995;107-117.
19. Zaino R.J., Ward S., Delgado G., Bundy B., Gore H., Fetter G., et al. Histopathologic predictors of the behavior of surgically treated stage IB squamous cell carcinoma of the cervix. Cancer. 69:1992;1750-1758. A Gynecologic Oncology Group study.
20. Barillot I., Horiot J.C., Pigneux J., Schraub S., Pourquier H., Daly N., et al. Carcinoma of the intact uterine cervix treated with radiotherapy alone: a French cooperative study: update and multivariate analysis of prognostics factors. Int J Radiat Oncol Biol Phys. 38:1997;969-978.
21. Irie T., Kigawa J., Minagawa Y., Itamochi H., Sato S., Akeshima R., et al. Prognosis and clinicopathological characteristics of Ib-IIb adenocarcinoma of the uterine cervix in patients who have had radical hysterectomy. Eur J Surg Oncol. 26:2000;464-467.
22. Lea J.S., Sheets E.E., Duska L.R., Miller D.S., Schorge J.O. Early-stage cervical adenocarcinoma treated by surgical intent: the role of para-aortic lymph node dissection. Gynecol Oncol. 84:2002;285-288.